gp100 Human Melanoma Peptide Vaccine with Incomplete Freund's Adjuvant

**Semantic type:** Immunologic Factor|Pharmacologic Substance

**Definition:** A vaccine consisting of synthetic glycoprotein 100 (gp100) melanoma antigen and incomplete Freund's adjuvant (IFA), an emulsifying agent and immune system stimulant, with antineoplastic activity. Vaccination with gp100 human melanoma peptide vaccine with IFA may stimulate the host immune system to direct cytotoxic T lymphocytes (CTL) against gp100 positive melanoma cells, resulting in decreased tumor growth. (NCI04)

**Synonyms:** - gp100 human melanoma peptide vaccine/incomplete Freund's adjuvant - gp100 human melanoma-associated antigen with incomplete Freund's adjuvant - gp100 human melanoma-associated antigen/incomplete Freund's adjuvant